No trading action warranted. These filings reflect standard, pre-arranged dividend reinvestments, not strategic insider buying. Monitor for larger discretionary purchases or changes in sentiment.
Price Chart
Executive Summary
GSK executives and associated persons acquired ordinary shares through dividend reinvestment under the company's Share Reward Plan on April 9, 2026. These are routine, non-discretionary transactions reflecting standard compensation plan activity, not new insider buying signals.
Key Facts
- Multiple PDMRs (Persons Discharging Managerial Responsibilities) and PCAs (Persons Closely Associated) acquired GSK ordinary shares on April 9, 2026.
- Transactions were executed via dividend reinvestment under the Company's Share Reward Plan, a standard, non-discretionary process.
- CEO Luke Miels acquired 2 shares at £21.3387; other executives acquired between 5 and 67 shares at the same price.
- Victoria Whyte (SVP & Company Secretary) and her associated person Iain Whyte made separate purchases at £21.5039, totaling 1,214 shares.
- All transactions occurred on the London Stock Exchange (XLON).
Financial Impact
Minimal. Total shares acquired by insiders are small in volume and value, representing routine plan activity rather than material investment.
Risk Factors
- Misinterpretation of routine transactions as bullish sentiment could lead to incorrect positioning.
- Future changes in insider transaction patterns (e.g., shift from reinvestment to open market buys) could signal changing confidence.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-003401 |
| Document: 0001654954-26-003401-index-headers.html | 0001654954-26-003401 |
| Document: 0001654954-26-003401-index.html | 0001654954-26-003401 |
| Document: 0001654954-26-003401.txt | 0001654954-26-003401 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 10, 2026 19w ago | 6-K | $25.12 $25.25 | ▲ +0.52% | ▼ −1.62% | $26.12 (+3.98%) |
Jun 9, 2026 19w ago | 6-K | $24.66 $25.50 | ▲ +3.41% | ▲ +1.60% | $26.12 (+5.92%) |
Jun 9, 2026 20w ago | 6-K | $24.66 $25.50 | ▲ +3.41% | ▲ +1.60% | $26.12 (+5.92%) |
Jun 1, 2026 21w ago | 6-K | $24.25 $24.66 | ▲ +1.69% | ▲ +4.44% | $26.12 (+7.71%) |
Jun 1, 2026 21w ago | 6-K | $24.25 $24.66 | ▲ +1.69% | ▲ +4.44% | $26.12 (+7.71%) |
May 28, 2026 21w ago | 6-K | $24.58 $24.66 | ▲ +0.33% | ▲ +0.01% | $26.12 (+6.27%) |
May 27, 2026 21w ago | 6-K | $25.57 $23.94 | ▼ −6.37% | ▼ −7.58% | $26.12 (+2.15%) |
May 26, 2026 21w ago | 6-K | $25.50 $24.25 | ▼ −4.90% | ▼ −5.99% | $26.12 (+2.43%) |
May 26, 2026 21w ago | 6-K | $25.50 $24.25 | ▼ −4.90% | ▼ −5.99% | $26.12 (+2.43%) |
May 22, 2026 22w ago | 6-K | $26.00 $24.25 | ▼ −6.73% | ▼ −8.39% | $26.12 (+0.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers